Treatment Foundations of the Cardiovascular System

CPR APPLICATIONS FOUNDATION · CHAPTER 6 · TREATMENT

Treatment Foundations of the Cardiovascular System

Organize the chapter before drilling into individual CPR concepts.

Supplemental foundation map: this page orients the detailed CPR Applications for Chapter 6. It is not part of the canonical CPR object inventory.

Move through Chapter 6

Normal Foundations

Open normal foundations →

Abnormal Foundations

Open abnormal foundations →

Treatment Foundations · You are here

Open treatment foundations →

6.36 · SOURCE CPR FOUNDATION

Concept

Cardiovascular therapy intentionally manipulates preload, afterload, contractility, heart rate, thrombosis, and neurohormonal tone. Step 1 usually tests why a drug class fits the physiology rather than asking for guideline memorization alone. Toxicity follows from the same mechanism that creates benefit.

Pattern

Most treatment stems provide a hemodynamic problem plus a comorbidity constraint. Hypertension, angina, MI, thrombus, arrhythmia, and heart failure each require moving a specific variable in the right direction. Asthma, CKD, diabetes, bradycardia, pregnancy, bleeding risk, or hyperkalemia may make the otherwise obvious drug unsafe.

Rule

  1. Define the treatment goal physiologically: decide whether the patient needs reduced preload, reduced afterload, slower heart rate, improved contractility, decongestion, anti-ischemia, or antithrombosis.
  2. Pick the class that moves the target variable: match drug mechanism to the dominant hemodynamic problem.
  3. Predict the adverse effect as the price of the mechanism: hypotension, bradycardia, renal effects, electrolyte changes, bleeding, and bronchospasm are mechanism-linked.

Applications

  • Hypertension → afterload or volume reduction
  • Angina → reduced oxygen demand or improved supply
  • ACS plaque rupture → antiplatelet therapy
  • Heart failure congestion → preload reduction
  • HFrEF remodeling → neurohormonal blockade
  • Tip: In atrial fibrillation, rate control, rhythm control, and thromboembolic risk reduction are separate treatment goals; the right priority depends on hemodynamic stability, symptoms, duration, and stroke risk.

CPR APPLICATIONS · ACTIVE REASONING

Match the treatment to the cardiovascular variable

Make a prediction before checking the explanation. Every worked answer is also available below without scripts. No learner answers are transmitted or retained.

Decision 1. A patient with symptomatic volume-overloaded heart failure has leg edema and pulmonary congestion. Which immediate goal best explains loop diuretic benefit?
Reveal worked answer and changed-variable prompt

Best answer: Reduce volume-related filling pressures and congestion. Correct. Loop diuretics promote sodium/water excretion and improve congestion symptoms; this is distinct from therapies with established long-term survival effects in selected populations.

Transfer: How does the objective differ from disease-modifying therapy for stable HFrEF?

Decision 2. A patient with plaque-rupture acute coronary syndrome receives an antiplatelet drug. What process is the direct target?
Reveal worked answer and changed-variable prompt

Best answer: Platelet activation and aggregation at an arterial thrombus. Correct. Plaque rupture exposes thrombogenic material and triggers platelet-rich arterial thrombosis.

Transfer: How does bleeding risk follow from the mechanism of antiplatelet benefit?

Decision 3. A patient with atrial fibrillation is stable and has a high estimated embolic stroke risk. Which treatment goal is conceptually separate from controlling ventricular rate?
Reveal worked answer and changed-variable prompt

Best answer: Stroke prevention with risk-appropriate antithrombotic management. Correct. Rate control, rhythm management, and stroke-risk reduction address different mechanisms and require individualized decisions.

Transfer: If the patient instead develops hemodynamic instability, what additional immediate management priority emerges?

Change the mechanism

Reference consequences without scripts
  • Clinical target: pulmonary congestion: Decongestion through appropriate diuresis reduces volume and filling pressures; monitor renal function and electrolytes.
  • Clinical target: plaque-related arterial thrombosis: Antiplatelet therapy limits platelet-mediated clot formation but increases bleeding risk.
  • Clinical target: atrial fibrillation with embolic risk: Evaluate stroke prevention independently of rate/rhythm decisions, using clinical risk and contraindications.

Explain it back: State the causal chain in your own words and identify which observation would falsify your first prediction.

These are educational, unscored self-checks rather than validated assessments or clinical treatment advice.

How to use this foundation map

  1. Identify the organizing mechanism.
  2. Recognize the pattern.
  3. Restate the rule without looking.
  4. Test transfer with the applications and question practice.

Pair CPR with the 5P Approach™ when solving cases and questions.